(Q48904140)

English

Microdose follicular phase gonadotropin-releasing hormone agonist (GnRH-a) compared with luteal phase GnRH-a for ovarian stimulation at in vitro fertilization.

scientific article published in December 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/10593374

Microdose follicular phase gonadotropin-releasing hormone agonist (GnRH-a) compared with luteal phase GnRH-a for ovarian stimulation at in vitro fertilization. (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/10593374

author name string

Leondires MP

1

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/10593374

Escalpes M

2

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/10593374

Segars JH

3

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/10593374

Scott RT Jr

4

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/10593374

Miller BT

5

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/10593374

language of work or name

0 references

publication date

1 December 1999

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/10593374

Fertility and Sterility

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/10593374

72

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/10593374

6

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/10593374

1018-1023

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/10593374

Induction of ovulation for in-vitro fertilisation using buserelin and gonadotropins

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900423-9

7 January 2021

Value of suppression with a gonadotropin-releasing hormone agonist prior to gonadotropin stimulation for in vitro fertilization.

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900423-9

7 January 2021

The routine use of gonadotropin-releasing hormone agonists prior to in vitro fertilization and gamete intrafallopian transfer: a meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900423-9

7 January 2021

Gonadotropin-releasing hormone analog design. Structure-function studies toward the development of agonists and antagonists: rationale and perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900423-9

7 January 2021

Ovarian response and outcome of in-vitro fertilization in patients treated with gonadotrophin-releasing hormone analogues in different phases of the menstrual cycle

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900423-9

7 January 2021

Follicular phase gonadotropin-releasing hormone agonist and human gonadotropins: a better alternative for ovulation induction in in vitro fertilization

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900423-9

7 January 2021

Different gonadotropin and leuprorelin ovulation induction regimens markedly affect follicular fluid hormone levels and folliculogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900423-9

7 January 2021

Prospective study of short and ultrashort regimens of gonadotropin-releasing hormone agonist in an in vitro fertilization program

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900423-9

7 January 2021

Gonadotropin-releasing hormone agonist-induced ovarian hyperstimulation: low-dose side effects in women and monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900423-9

7 January 2021

Enhancement of ovarian responsiveness with microdoses of gonadotropin-releasing hormone agonist during ovulation induction for in vitro fertilization.

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900423-9

7 January 2021

Improved controlled ovarian hyperstimulation in poor responder in vitro fertilization patients with a microdose follicle-stimulating hormone flare, growth hormone protocol

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900423-9

7 January 2021

Clinical and endocrine effects of a microdose GnRH agonist flare regimen administered to poor responders who are undergoing in vitro fertilization

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900423-9

7 January 2021

Prognostic assessment of female fecundity

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900423-9

7 January 2021

Gonadotropin responsiveness to ultralow-dose leuprolide acetate administration in baboons

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900423-9

7 January 2021

Gonadotropin suppression with oral contraceptives before in vitro fertilization

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900423-9

7 January 2021

Early follicular rise of serum progesterone concentration in response to a flare-up effect of gonadotrophin-releasing hormone agonist impairs follicular recruitment for in-vitro fertilization

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900423-9

7 January 2021

High fecundity of amenorrhoeic women in embryo-transfer programmes

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900423-9

7 January 2021

The long protocol of administration of gonadotropin-releasing hormone agonist is superior to the short protocol for ovarian stimulation for in vitro fertilization

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900423-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Type of stimulation protocol affects oocyte maturity, fertilization rate, and cleavage rate after intracytoplasmic sperm injection.

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900423-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of leuprolide acetate on follicular fluid hormone composition at oocyte retrieval for in vitro fertilization

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900423-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0015-0282(99)00423-9

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/10593374

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/10593374

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48904140&oldid=1387305997"